Autres langues Alfresa Holdings Corporation

Actions

2784

JP3126340003

Equipement, fournitures et distribution médicale

Temps Différé Japan Exchange Autres places de cotation 06:32:57 05/08/2026			Varia. 5j.	Varia. 1 janv.
2 235,00 ^JPY	-0,97%		-9,07%	-8,08%

15/05	Alfresa Holdings Corporation autorise un programme de rachat d'actions.	CI
15/05	Alfresa Holdings Corporation (TSE:2784) annonce un rachat d'actions portant sur 6'307'800 titres, soit 3.46% du capital, pour 14'999.95 millions de yens.	CI

Autres langues

30/07	Ember LifeSciences and Alfresa Corporation Enter into Capital and Business Alliance to Improve the Quality of the Pharmaceutical Cold Chain in Japan
01/07	Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation
22/06	Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100
27/05	ReeNT Co., Ltd. announced that it expects to receive ¥600 million in funding from Alfresa Holdings Corporation
27/05	Alfresa Holdings Corporation concluded a share transfer agreement to acquire Nagashima Medical Instruments Co., Ltd. from Nagashima Holdings Co., Ltd.
20/05	Alfresa : Acquisition of ISMS Certification by GEKKA WORKS Co., Ltd. for Managing Provision of its Communication Service for Healthcare and Caregiving Professionals
18/05	Alfresa Holdings Corporation's Equity Buyback announced on May 15, 2026, has closed with 6,307,800 shares, representing 3.47% for ¥14,999.95 million.
18/05	Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2026.
18/05	Alfresa : Notice on the Decision of Terms of the 1st Issuance of Stock Acquisition Right via Third-Party Allotment for Acquisition of Own Shares via Fully Committed Share Repurchase (Japanese ASR)
18/05	Alfresa : Notice of the Result and Completion of the Acquisition of Own Shares through Off-Auction Own Share Repurchase Trading System(ToSTNeT-3)
15/05	Alfresa Holdings Corporation authorizes a Buyback Plan.
15/05	Alfresa Holdings Corporation announces an Equity Buyback for 6,307,800 shares, representing 3.46% for ¥14,999.95 million.
15/05	Alfresa : Briefing on Business Results for the Fiscal Year Ended March 2026 （2,633KB） PDF
15/05	Alfresa Holdings Corp - to buy back up to 3.5% of own shares worth about 15 billion yen
15/05	Alfresa : Notice Regarding Partial Amendments to the Articles of Incorporation
15/05	Alfresa : Consolidated Financial Results for the Fiscal Year Ended March 31, 2026(Under Japanese GAAP)
15/05	Alfresa : Financial Results Summary for the Fiscal Year Ended March 31, 2026
15/05	Alfresa Holdings Corporation Announces Cash Dividend for the Year-End of the Fiscal Year Ended March 31, 2026, Payable on June 2, 2026; Provides Cash Dividend Guidance for the Second Quarter-End and Year-End of the Fiscal Year Ending March 31, 2027
15/05	Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2026 and for the Fiscal Year Ending March 31, 2027
15/05	Alfresa : Notice Regarding the Establishment of a Collaborative Research Laboratory in Clinical and Emerging Infectious Diseases at Hiroshima University Hospital Aimed at Strengthening Countermeasures for a Tick-Borne Infectious Disease Deepening Collaboration Between Industry and Academia to Advance Research and Education, Promote Implementation in Industry, and Contribute to Society
28/04	Alfresa : Notice Regarding the Business Alliance Between Alfresa Healthcare Corporation and AdInte Co., Ltd. to Jointly Develop a Retail Media Business to Support the Sales Promotion Activities of Manufacturers and Retailers
28/04	Alfresa : Conclusion of a Comprehensive Partnership Agreement Between Meisho Co., Ltd. and Komatsu City, Ishikawa Prefecture, to Promote the Health of and Realize Safe and Comfortable Lives for the City’s Residents
07/04	Healios Secures 144 Million Yen Initial Order from Alfresa's Korean Unit for Cosmetic Raw Material
31/03	Alfresa : Notice Regarding the Business Alliance Between Mwis Corporation and Ark Medical Solutions Inc. to Expand the Latter’s CRO Business
31/03	Notice Regarding Achievement of ISO 9001 Certification by Subsidiaries:Efforts to Improve Logistics Quality in the Alfresa Group